TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS July 3, 1987
